bromocriptine has been researched along with dihydroergotoxine in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (90.91) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 1 (4.55) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldstein, M; Hata, F; Lew, JY; Ohashi, T | 1 |
| Asper, H; Bürki, HR; Ruch, W; Züger, PE | 1 |
| Berde, B | 1 |
| Bürki, HR; Jaton, AL; Loew, DM; Vigouret, JM; Züger, PE | 1 |
| Loizzo, A; Longo, VG | 1 |
| Portaleone, P | 1 |
| Jaton, AL; Loew, DM; Vigouret, JM | 1 |
| Canonico, PL | 1 |
| Minakami, H; Satoh, T; Tamada, T; Tamura, T | 1 |
| Chiodini, PG; Dallabonzana, D; Liuzzi, A; Oppizzi, G; Verde, GG | 1 |
| Cocchi, D; Craveri, A; Landi, G; Mailland, F; Masu, AM; Müller, EE; Poli, M | 1 |
| Conti, A; Faglia, G; Mailland, F; Muratori, M; Togni, E; Travaglini, P; Zanotti, A | 1 |
| Bottiglioni, F; de Aloysio, D; Fabiani, AG; Pamparana, F; Zanotti, A | 1 |
| Clark, BJ | 1 |
| Carruba, MO; Liberini, P; Memo, M; Missale, C; Spano, P | 1 |
| Cherchi, A; Gessa, GL; Mercuro, G; Rivano, AC; Rossetti, Z; Ruscazio, M; Stefanini, E; Tocco, L | 1 |
| Jaton, A; Loew, DM; Vigouret, JM | 1 |
| Dieguez, C; Foord, SM; Hall, R; Jasani, B; Peters, JR; Scanlon, MF | 1 |
| Bethea, CL; Jaffe, RB; Ramsdell, JS; Weiner, RI; Wilson, CB | 1 |
| Brodie, M; Radulovacki, M; Walovitch, R; Yanik, G | 1 |
| Cestari, R; Lojacono, L; Missale, C; Missale, G; Raddino, R; Sigala, S; Spano, PF | 1 |
| Althaus, M; Amalou, Z; Appel, K; Castell, JV; Gómez-Lechón, MJ; Retzow, A; Rose, T | 1 |
3 review(s) available for bromocriptine and dihydroergotoxine
| Article | Year |
|---|---|
Pharmacology of ergot alkaloids in clinical use.
Topics: Animals; Brain Diseases; Bromocriptine; Dihydroergotamine; Dihydroergotoxine; Dopamine Antagonists; Ergot Alkaloids; Ergotamine; Female; Humans; Methysergide; Migraine Disorders; Parkinson Disease; Pituitary Gland; Prolactin; Receptors, Adrenergic; Receptors, Dopamine; Uterus; Vasoconstriction | 1978 |
Medical treatment of pituitary adenomas: effects on tumor growth.
Topics: Adenoma; Adrenocorticotropic Hormone; Bromocriptine; Dihydroergotoxine; Dopamine; Drug Administration Schedule; Ergolines; Growth Hormone; Levodopa; Lisuride; Metergoline; Methysergide; Pergolide; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1985 |
Is stimulation of prejunctional dopamine receptors an antihypertensive principle?
Topics: Animals; Blood Pressure; Bromocriptine; Dihydroergotoxine; Humans; Receptors, Dopamine | 1987 |
3 trial(s) available for bromocriptine and dihydroergotoxine
| Article | Year |
|---|---|
Effect of hydergine in hyperprolactinemia.
Topics: Adolescent; Adult; Anovulation; Bromocriptine; Dihydroergotoxine; Dose-Response Relationship, Drug; Female; Humans; Hyperprolactinemia; Prolactin; Random Allocation | 1989 |
Prolactin lowering effect of dihydroergokryptine in rat and in man.
Topics: Adult; Animals; Bromocriptine; Cimetidine; Dihydroergotoxine; Female; Humans; Male; Prolactin; Random Allocation; Rats; Rats, Inbred Strains; Reserpine; Sulpiride | 1986 |
Dihydroergocristine in stopping lactation: double-blind study vs bromocriptine.
Topics: Adult; Bromocriptine; Dihydroergotoxine; Double-Blind Method; Female; Humans; Lactation; Postpartum Period; Pregnancy | 1988 |
16 other study(ies) available for bromocriptine and dihydroergotoxine
| Article | Year |
|---|---|
The interactions of bromocriptine and lergotrile with dopamine and alpha-adrenergic receptors.
Topics: Acetonitriles; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Apomorphine; Binding Sites; Brain; Bromocriptine; Butaclamol; Cattle; Cerebral Cortex; Corpus Striatum; Dihydroergotoxine; Dopamine; Ergolines; Haloperidol; In Vitro Techniques; Osmolar Concentration; Rats; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Synaptosomes; Tyrosine 3-Monooxygenase | 1977 |
Bromocriptine, dihydroergotoxine, methysergide, d-LSD, CF25--397, and 29--712: effects on the metabolism of the biogenic amines in the brain of the rat.
Topics: Animals; Biogenic Amines; Brain; Bromocriptine; Dihydroergotoxine; Dopamine; Ergolines; Lysergic Acid Diethylamide; Male; Methysergide; Nitriles; Pyridines; Rats; Receptors, Drug; Reserpine; Serotonin | 1978 |
Neurochemical and neuropharmacological investigations with four ergot derivatives: bromocriptine, dihydroergotoxine, CF 25-397 and CM 29-712.
Topics: Animals; Behavior, Animal; Brain; Bromocriptine; Catecholamines; Chemical Phenomena; Chemistry; Dihydroergotoxine; Electroencephalography; Ergolines; Humans; Locomotion; Male; Mice; Morphine; Movement Disorders; Rabbits; Rats; Receptors, Dopamine; Reserpine; Sleep; Stereotyped Behavior | 1978 |
Evaluation of the central effects of ergot alkaloids by means of electroencephalography.
Topics: Animals; Behavior, Animal; Brain; Bromocriptine; Dihydroergotoxine; Electroencephalography; Ergolines; Ergot Alkaloids; Ergotamine; Mice; Rabbits; Rats; Receptors, Dopamine | 1978 |
Bromocriptine and hydergine: a comparison on striatal or hypothalamic adenylate cyclase activity.
Topics: Adenylyl Cyclases; Animals; Bromocriptine; Corpus Striatum; Dihydroergotoxine; Dopamine; Hypothalamus; Rats | 1978 |
Neuropharmacological investigations with two ergot alkaloids, Hydergine and bromocriptine.
Topics: Activity Cycles; Animals; Behavior, Animal; Bromocriptine; Dihydroergotoxine; Ergolines; Ergoloid Mesylates; Humans; Mice; Morphine; Rats; Stereotyped Behavior | 1976 |
D-2 dopamine receptor activation reduces free [3H]arachidonate release induced by hypophysiotropic peptides in anterior pituitary cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenylate Cyclase Toxin; Angiotensin II; Animals; Arachidonic Acid; Arachidonic Acids; Benzazepines; Bromocriptine; Cells, Cultured; Dihydroergotoxine; Dopamine; Dopamine Antagonists; Female; Indomethacin; Kinetics; Masoprocol; Pertussis Toxin; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Sulpiride; Tritium; Virulence Factors, Bordetella | 1989 |
Dihydroergocriptine in management of microprolactinomas.
Topics: Adult; Bromocriptine; Dihydroergotoxine; Drug Administration Schedule; Female; Humans; Pituitary Neoplasms; Prolactin; Time Factors | 1987 |
Characterization of dopamine receptors associated with aldosterone secretion in rat adrenal glomerulosa.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Adrenal Cortex; Aldosterone; Animals; Benzazepines; Bromocriptine; Dihydroergotoxine; Haloperidol; Lisuride; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereoisomerism; Sulpiride | 1986 |
[Peripheral presynaptic dopamine receptors control the release of norepinephrine and arterial pressure in humans].
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Apomorphine; Blood Pressure; Bromocriptine; Dihydroergotoxine; Domperidone; Double-Blind Method; Heart Rate; Humans; Hypertension; Male; Norepinephrine; Random Allocation; Receptors, Dopamine | 1987 |
Neuropharmacology of bromocriptine and dihydroergotoxine (hydergine).
Topics: Animals; Behavior, Animal; Brain; Bromocriptine; Dihydroergotoxine; Dose-Response Relationship, Drug; Humans; Neurotransmitter Agents; Peripheral Nerves; Receptors, Dopamine; Receptors, Neurotransmitter; Receptors, Serotonin | 1980 |
Hypothyroid pituitary cells in culture: an analysis of thyrotropin and prolactin responses to dopamine (DA) and DA receptor binding.
Topics: Animals; Apomorphine; Bromocriptine; Cells, Cultured; Dihydroergotoxine; Dopamine; Hypothyroidism; Male; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Structure-Activity Relationship; Thyrotropin | 1984 |
Characterization of the dopaminergic regulation of human prolactin-secreting cells cultured on extracellular matrix.
Topics: Adenoma; Adult; Apomorphine; Bromocriptine; Cells, Cultured; Dihydroergotoxine; Dopamine; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin | 1982 |
Bromocriptine, dihydroergotoxine and sleep in rats: effects of repeated administration.
Topics: Animals; Bromocriptine; Dihydroergotoxine; Male; Rats; Receptors, Dopamine; Sleep; Wakefulness | 1981 |
Opposing roles for D-1 and D-2 dopamine receptors in the regulation of lower esophageal sphincter motility in the rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Dihydroergotoxine; Dopamine; Dopamine Agents; Ergolines; Esophagogastric Junction; Fenoldopam; In Vitro Techniques; Male; Peristalsis; Phentolamine; Prazosin; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1994 |
In vitro identification of the cytochrome P450 isoform responsible for the metabolism of alpha-dihydroergocryptine.
Topics: Aged; Animals; Bromocriptine; Cell Line; Cells, Cultured; Chromatography, High Pressure Liquid; Cricetinae; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dihydroergotoxine; Dopamine Agonists; Dose-Response Relationship, Drug; Epithelial Cells; Female; Gas Chromatography-Mass Spectrometry; Hepatocytes; Humans; Hydroxytestosterones; Liver; Male; Middle Aged; Mixed Function Oxygenases; Models, Chemical; Protein Isoforms; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Time Factors | 2000 |